Overview
This document provides an overview of the methods used for RNA sequencing and subsequent data analysis. This pipeline was designed for studying Patient-Derived Xenograft (PDX) tumor tissue. The workflow includes sample collection, RNA extraction, RNA sequencing, and comprehensive data analysis.
Method
Sample Collection:
- Material Used: Snap frozen PDX tumor tissue.
RNA Extraction:
Kit Used: Allprep DNA/RNA Mini Kit (Cat. 80204 QIAGEN).
RNA Sequencing Kit/Platform
- Sequencing Kit: Illumina TruSeq Standard Total RNA Kit with RiboZero Plus.
- Sequencing Goal: Achieving approximately 50 million reads per sample to ensure depth and coverage for robust downstream analysis.
- Sequencing Platform: Novaseq, known for its high-throughput sequencing capability.
Analysis
Applied Tools and Methodology
- Xengsort Package:
- Function: Used on FASTQ files to differentiate and split raw FASTQ files into human and mouse reads.
- Data Organization: Data saved in separate folders for host and graft analysis.
- Host Folder: "20210927 Host Analysis"
- Graft Folder: "20210927 Host Analysis"
Patient sample 21A1 was established orthotopically, excluded for LRT DESeq2 analysis due to different model systems.
Host Analysis (Folder: 20220109analysis; ignore other folders):
Gene Set Enrichment Analysis (LRT Ranked Gene)
Differential expression cluster analysis
- WGCNA Analysis
- Result Sheet Format:
- Patient Meta Data
- Raw Counts
- Normalized Counts
- Variance Stabilized Counts
- LRT Ranked Genes with Differential Expression Statistic
- Top 1000 LRT Ranked Gene Hallmark Gene Set Enrichment Analysis
Graft Analysis (Folder: 20220109analysis):
Gene Set Enrichment Analysis
Gene Set Variance Analysis
- Result Sheet Format:
- Patient Meta Data
- Raw Counts
- Normalized Counts
- Variance Stabilized Counts
- LRT Ranked Genes with Differential Expression Statistic
- Top 1000 LRT Ranked Gene Hallmark Gene Set Enrichment Analysis